| 前收市價 | 53.10 |
| 開市 | 52.67 |
| 買盤 | 52.38 x 700 |
| 賣出價 | 52.44 x 700 |
| 今日波幅 | 52.37 - 52.85 |
| 52 週波幅 | 42.63 - 55.72 |
| 成交量 | |
| 平均成交量 | 2,366,234 |
| 市值 | 131.343B |
| Beta 值 (5 年，每月) | 0.41 |
| 市盈率 (最近 12 個月) | 28.79 |
| 每股盈利 (最近 12 個月) | 1.82 |
| 業績公佈日 | 2024年10月25日 |
| 遠期股息及收益率 | 2.04 (3.98%) |
| 除息日 | 2024年5月09日 |
| 1 年預測目標價 | 59.89 |
ZacksPharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.
Investor's Business DailyAstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment
AstraZeneca stock skidded Thursday despite strong quarterly sales as an FDA panel met to discuss its lung cancer treatment.
Motley FoolSanofi (SNY) Q2 2024 Earnings Call Transcript
SNY earnings call for the period ending June 30, 2024.
